Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15-Reference-Cited by-同舟云学术

Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15

Published:2011-05-25 Issue:1 Volume:130 Page:48-58
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ishii Hideyuki,Takahara Miki,Nagato Toshihiro,Kis Loránd L.,Nagy Noémi,Kishibe Kan,Harabuchi Yasuaki,Klein Eva

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Lethal midline granuloma (granuloma gangraenescens) at autopsy; report of a case and review of literature;Spear;Bull Johns Hopkins Hosp,1956

2. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies;Harabuchi;Cancer,1996

3. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions;Aozasa;Int J Cancer,1989

4. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma;Harabuchi;Lancet,1990

5. Nasal T-cell lymphoma: a clinicopathologic entity associated with a peculiar phenotype and with Epstein-Barr virus;Kanavaros;Blood,1993

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T‐Cell Lymphoma;Advanced Science;2023-11-10

2. The role of interleukin-15 in the development and treatment of hematological malignancies;Frontiers in Immunology;2023-04-20

3. EBV and Lymphomagenesis;Cancers;2023-04-04

4. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy;Cancer Immunology, Immunotherapy;2023-02-22

5. 功成り名遂げて身退くは, 天の道なり;Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo);2022-10-20